Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Waiczies, Helmar ^a,b   Lepore, Stefano ^a   Janitzek, Nicole ^a   Hagen, Ulrike ^a   Seifert, Frank ^b   Ittermann, Bernd ^b   Purfürst, Bettina ^a   Pezzutto, Antonio ^a,c   Paul, Friedemann ^a,c   Niendorf, Thoralf ^a   Waiczies, Sonia ^a,d  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF MALTA   (Malta)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CROWN ETHER DERIVATIVE; FLUOROCARBON; MAJOR HISTOCOMPATIBILITY ANTIGEN; NANOPARTICLE; PERFLUORO 15 CROWN 5 ETHER; PERFLUORO 15 CROWN 5 ETHER F 19; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL LABELING; CELL MATURATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; EMULSION; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PHAGOCYTOSIS; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CELL SHAPE; CHEMISTRY; CYTOLOGY; IMMUNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; T LYMPHOCYTE;

MURINAE;

ANIMALS; CELL DIFFERENTIATION; CELL SHAPE; DENDRITIC CELLS; EMULSIONS; FLUOROCARBONS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; PARTICLE SIZE; PHAGOCYTOSIS; T-LYMPHOCYTES;

EID: 79960451220     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021981     Document Type: Article

References (26)

1. Banchereau J, Schuler-Thurner B, Palucka AK, Schuler G, (2001) Dendritic cells as vectors for therapy. Cell 106: 271-274.
2. Mackensen A, Krause T, Blum U, Uhrmeister P, Mertelsmann R, et al. (1999) Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. Cancer Immunol Immunother 48: 118-122.
3. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, et al. (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23: 1407-1413.
4. Brooks RA, Brunetti A, Alger JR, Di Chiro G, (1989) On the origin of paramagnetic inhomogeneity effects in blood. Magn Reson Med 12: 241-248.
5. Ahrens ET, Flores R, Xu H, Morel PA, (2005) In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 23: 983-987.
6. Lauterbur PC, (1973) Image Formation by Induced Local Interactions- Examples Employing Nuclear Magnetic-Resonance. Nature 242: 190-191.
7. Holland GN, Bottomley PA, Hinshaw WS, (1977) F-19 Magnetic-Resonance Imaging. Journal of Magnetic Resonance 28: 133-136.
8. Liu MS, Long DM, (1977) Perfluoroctylbromide as a diagnostic contrast medium in gastroenterography. Radiology 122: 71-76.
9. Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, et al. (2007) 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J 21: 1647-1654.
10. Ruiz-Cabello J, Walczak P, Kedziorek DA, Chacko VP, Schmieder AH, et al. (2008) In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn Reson Med 60: 1506-1511.
11. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET, (2007) Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med 58: 725-734.
12. Dobrovolskaia MA, McNeil SE, (2007) Immunological properties of engineered nanomaterials. Nat Nanotechnol 2: 469-478.
13. Aderem A, Underhill DM, (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17: 593-623.
14. Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, et al. (1997) B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6: 303-313.
15. Austyn JM, Kupiec-Weglinski JW, Hankins DF, Morris PJ, (1988) Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J Exp Med 167: 646-651.
16. Sallusto F, Lanzavecchia A, (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109-1118.
17. Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, et al. (1997) Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 185: 317-328.
18. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, et al. (1995) Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 181: 2237-2247.
19. Champion JA, Mitragotri S, (2006) Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A 103: 4930-4934.
20. Menges M, Rossner S, Voigtlander C, Schindler H, Kukutsch NA, et al. (2002) Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 195: 15-21.
21. van Zijverden M, Granum B, (2000) Adjuvant activity of particulate pollutants in different mouse models. Toxicology 152: 69-77.
22. Pelkmans L, (2005) Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim Biophys Acta 1746: 295-304.
23. Mitragotri S, Lahann J, (2009) Physical approaches to biomaterial design. Nat Mater 8: 15-23.
24. Bendix I, Pfueller CF, Leuenberger T, Glezeva N, Siffrin V, et al. (2010) MAPK3 deficiency drives autoimmunity via DC arming. Eur J Immunol.
25. Shastri N, Gonzalez F, (1993) Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. J Immunol 150: 2724-2736.
26. Sommermeyer D, Neudorfer J, Weinhold M, Leisegang M, Engels B, et al. (2006) Designer T cells by T cell receptor replacement. Eur J Immunol 36: 3052-3059.